SU2C Initiative to Increase Diversity in Cancer Clinical Trials


Applied Clinical Trials

Stand Up To Cancer (SU2C) announced an initiative to increase minority representation in cancer clinical trials. All future SU2C-supported research grant proposals will now be required to include and address crucial issues related to recruitment and retention of patients from ethnic groups to improve diverse participation in cancer clinical trials.

For more information on this initiative, click here. 

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.